Osaic Holdings’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$278K Buy
15,136
+3,093
+26% +$56.9K ﹤0.01% 3324
2025
Q1
$232K Sell
12,043
-1,484
-11% -$28.6K ﹤0.01% 3505
2024
Q4
$241K Buy
13,527
+1,488
+12% +$26.6K ﹤0.01% 3434
2024
Q3
$264K Buy
12,039
+11,589
+2,575% +$254K ﹤0.01% 3429
2024
Q2
$3.51K Sell
450
-11,411
-96% -$89K ﹤0.01% 6216
2024
Q1
$49.1K Sell
11,861
-132,095
-92% -$547K ﹤0.01% 4749
2023
Q4
$376K Sell
143,956
-25,622
-15% -$66.9K ﹤0.01% 3396
2023
Q3
$317K Buy
169,578
+1,200
+0.7% +$2.24K ﹤0.01% 3641
2023
Q2
$423K Buy
168,378
+12,809
+8% +$32.2K ﹤0.01% 3287
2023
Q1
$272K Buy
155,569
+109,395
+237% +$191K ﹤0.01% 3618
2022
Q4
$197K Buy
46,174
+5,800
+14% +$24.7K ﹤0.01% 3852
2022
Q3
$48K Buy
40,374
+29,774
+281% +$35.4K ﹤0.01% 4933
2022
Q2
$11K Buy
10,600
+1,000
+10% +$1.04K ﹤0.01% 6009
2022
Q1
$24K Sell
9,600
-150
-2% -$375 ﹤0.01% 5566
2021
Q4
$26K Sell
9,750
-1,330
-12% -$3.55K ﹤0.01% 5602
2021
Q3
$56K Buy
11,080
+5,100
+85% +$25.8K ﹤0.01% 5015
2021
Q2
$44K Buy
+5,980
New +$44K ﹤0.01% 5134